Cytogenetic Analysis in Acute Myeloid Leukaemia
Cytogenetic analysis is an integral part of the diagnostic work-up of the patient with acute myeloid leukaemia. Conventional cytogenetic analysis relies on obtaining a good quality bone marrow specimen in a timely fashion and setting up at least two short-term cultures. A 15–24-h culture and a 48-h synchronised culture are routinely set up but as the cytogenetics result is often required urgently to determine the type of therapy to be administered, analysis is undertaken using the overnight culture in the first instance. Rapid and accurate analysis relies on obtaining high-quality G-banding. Knowledge of the conditions affecting banding is therefore essential.
- Introduction
- Gene Therapy Vectors Harboring AFP Regulatory Sequences: Preparation of an Adenoviral Vector
- Drug Ratio-Dependent Antagonism: A New Category of Multidrug Resistance and Strategies for Its Circumvention
- Imaging Metastatic Cell Trafficking at the Cellular Level In Vivo with Fluorescent Proteins
- High-Resolution Quantitative Methylation Analysis of MicroRNA Genes Using Pyrosequencing
- Detection of Telomerase Activity in Lung Cancer Tissues
- Histopathological Assessment of Metastasis
- Assessment of Gelatinases (MMP-2 and MMP-9) by Gelatin Zymography
- Myocardial Infarction: Animal Models
- Enrichment of Methylated DNA by Methyl-CpG Immunoprecipitation